Xilio Therapeutics, Inc.XLONASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
0.00
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-0.52
Historical baseline
PeriodValueYoY Change
20250.00+100.0%
2024-0.88-343.3%
2023-0.20+76.3%
2022-0.84+29.4%
2021-1.18-679.7%
2020-0.15+59.9%
2019-0.38-